ICU Medical, Inc.

67
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US44930G1076
USD
126.96
1.11 (0.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
ICU Medical, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
4.00
-66.00
-78.00
-114.00
123.00
97.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-90.00
-2.00
-135.00
-303.00
15.00
-16.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
179.00
204.00
166.00
-62.00
267.00
222.00
Cash Flow from Investing Activities
122.00
-88.00
-87.00
-1,909.00
-90.00
-98.00
Cash Flow from Financing Activities
-311.00
-55.00
-35.00
1,637.00
-16.00
0.00
Net Cash Inflow / Outflow
0.00
54.00
45.00
-344.00
156.00
127.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
8.00
-4.00
3.00
-9.00
-3.00
2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of ICU Medical, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
4.358
-8.744
12.00
149.84%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-90.044
-66.106
-24.00
-36.21%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
179.847
-2.01599999999999
181.00
9020.98%
Cash Flow from Investing Activities
122.229
-116.904
238.00
204.56%
Cash Flow from Financing Activities
-311.525
-3.38
-308.00
-9116.72%
Net Cash Inflow / Outflow
-0.603
-121.321
121.00
99.50%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
8.846
0.979
8.00
803.58%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -11.85% vs 22.76% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
179.85
204.03
-11.85%